Enovix Sees Unusually High Options Volume (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVX) was the recipient of some unusual options trading on Monday. Stock traders acquired 20,888 call options on the stock. This is an increase of 29% compared to the average daily volume of 16,241 call options.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ENVX. Private Advisor Group LLC lifted its position in shares of Enovix by 2.7% in the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after acquiring an additional 1,242 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares in the last quarter. Equitable Holdings Inc. grew its holdings in shares of Enovix by 10.9% during the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after purchasing an additional 1,342 shares during the last quarter. NewEdge Advisors LLC grew its holdings in Enovix by 4.7% during the 1st quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock worth $215,000 after acquiring an additional 1,853 shares during the last quarter. Finally, Mariner LLC increased its holdings in shares of Enovix by 3.4% in the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock valued at $582,000 after purchasing an additional 1,921 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $25.00 price objective on shares of Enovix in a research note on Thursday. TD Cowen decreased their target price on shares of Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. B. Riley Financial lowered their price target on Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Thursday. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Finally, Benchmark dropped their target price on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.86.

Enovix Stock Down 18.9%

Shares of ENVX stock traded down $0.83 during trading hours on Monday, hitting $3.56. 28,511,475 shares of the company were exchanged, compared to its average volume of 6,533,993. The stock has a market capitalization of $776.61 million, a price-to-earnings ratio of -4.40 and a beta of 2.32. The business’s 50-day simple moving average is $5.33 and its two-hundred day simple moving average is $5.86. The company has a debt-to-equity ratio of 2.46, a quick ratio of 9.37 and a current ratio of 9.71. Enovix has a one year low of $3.52 and a one year high of $14.21.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. The business had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The business’s quarterly revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Sell-side analysts predict that Enovix will post -0.78 EPS for the current fiscal year.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.